Do the Models We Trust Know They're Biased? Framing Effects and Introspection Across Three LLMs

Bhargavi Bhaskar

We tested whether three LLMs we might trust for decisions inherit the human framing bias of choosing differently between mathematically identical gain- and loss-framed gambles and whether they recognize it, across both monetary and stipulated affective stakes.

Reviewer's Comments

Reviewer's Comments

Arrow
Arrow
Arrow

The project investigates framing effects in three contemporary LLMs across monetary and affective domains, demonstrating that none of the models behave rationally under framing. The study extends the classic monetary gain-loss paradigm to affective stakes and introduces a metacognitive probe to assess whether models recognize their own biases. However, the main methodological weakness lies in the limited sample size and lack of blinding in the experimental design. With only 15 samples per condition, the results may not be robust enough to generalize beyond the tested scenarios. Additionally, while the study controls for some biases like option-order counterbalance, it does not account for potential confounding factors that could influence model responses.

To improve the rigor of the findings, increasing the sample size and implementing blinding techniques would help mitigate selection bias and enhance the reliability of the results. Furthermore, extending the study to include a larger variety of models and domains could provide more comprehensive insights into framing effects across different contexts. Despite these limitations, the project offers valuable empirical evidence on LLM behavior and opens avenues for future research, particularly in understanding the internal mechanisms that drive model decision-making.

Combining a known human framing bias with a test of whether models can recognize their own susceptibility is a distinctive part of this paper. The money-versus-affect comparison extends that idea, the main framing effects are reported with bootstrap intervals, and the discussion of failed approaches is unusually useful. I also found the result that models often recognize their susceptibility while misidentifying its direction particularly interesting.

A few places I would push:

1. Resolve the order confound. Related Work says both option order and outcome order were counterbalanced, but Methods lists only option order, and the printed items consistently place the good outcome first for gains and the bad outcome first for losses.

2. Add an unframed baseline and revise the abstract. Without an unframed condition, the gain/loss comparison cannot tell whether gains reduce risk-taking, losses increase it, or both. The abstract also describes self-report as an unreliable guide to behavior without noting that most self-reports were in fact accurate, which gives a more negative impression than the results support.

A few smaller fixes would help presentation: caption and number the figure, reference it from the text, remove the orphan table label, and repair the broken table cross-reference.

Finally, the affective comparison needs an aversive condition. Methods describes unpleasant affect, but the experiment does not actually include a negative affective outcome. As a result, the money-versus-affect comparison currently mixes outcome domain with valence. Adding a genuinely unpleasant affective condition would make that comparison much easier to interpret.

Cite this work

@misc {

title={

(HckPrj) Do the Models We Trust Know They're Biased? Framing Effects and Introspection Across Three LLMs

},

author={

Bhargavi Bhaskar

},

date={

},

organization={Apart Research},

note={Research submission to the research sprint hosted by Apart.},

howpublished={https://apartresearch.com}

}

Recent Projects

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

PROTEUS (PROTein Evaluation for Unusual Sequences): Structure-Informed Safety Screening for de novo and Evasion-Prone Protein-Coding Sequences

AI protein design tools like RFdiffusion, ProteinMPNN, and Bindcraft make it trivial to produce low-homology sequences that fold into active, potentially hazardous architectures. However, sequence homology-based biosafety screening tools cannot detect proteins that pose functional risk through structurally novel mechanisms with no sequence precedent. We present a tiered computational pipeline that addresses this gap by combining MMseqs2 sequence alignment with structure-based comparison via FoldSeek and DALI against curated toxin databases totaling ~34,000 entries. AlphaFold2-predicted structures are screened for both global fold similarity (FoldSeek) and local active/allosteric site geometry (DALI), capturing convergent functional hazards that sequence screening misses. The pipeline was validated against a panel of toxins, benign proteins, structural mimics, and de novo-designed Munc13 binders, as well as modified ricin variants with residue substitutions. We additionally tested robustness to partial-synthesis evasion, where a bad actor submits multiple shorter coding sequences intended for downstream reassembly into a full toxin-coding gene. We found that while sequence-based screening did not identify any de novo ricin analogues with high certainty, the combined pipeline with FoldSeek and DALI identified all 24 tested de novo ricins as toxic.

Read More

OliGraph: graph-based screening of large oligopools

Existing synthesis screening tools cannot evaluate short oligonucleotide pools, whose overlapping fragments can be reassembled into regulated sequences via polymerase cycling assembly (PCA) yet fall below gene-length detection thresholds. We present OliGraph, an open-source tool that constructs a bi-directed overlap graph from an oligonucleotide pool and extracts contigs for downstream gene-length screening. An optional PCA mode retains only cross-strand overlaps consistent with PCA chemistry. We validated OliGraph in a blinded study across ten simulated pools (70–9,184 oligonucleotides, 30–300 bp) spanning four risk categories. BLAST screening of individual oligonucleotides failed to identify sequences of concern in most pools: three returned zero hits, and vector noise obscured true positives in the remainder. After OliGraph assembly, contig-level BLAST matched the longest assembled sequences (up to 1,905 bp) to sequences of concern at 97–100% identity. In one pool, assembly collapsed 1,634 individual BLAST results into 10 hits from a single contig, all assigned to the same source organism. PCA mode correctly distinguished assemblable from non-assemblable fragments within the same pool. Two pools with no assemblable structure yielded no contigs. OliGraph processed all pools in under 0.2 seconds, fast enough for real-time order screening and consistent with proposals to bring oligonucleotide orders within the scope of synthesis screening regulation.

Read More

BioRT-Bench: A Multi-Attack Red-Teaming Benchmark for Bio-Misuse Safeguards in Frontier LLMs

Frontier AI laboratories are expected to maintain safeguards against biological misuse, but whether deployed models actually refuse bio-misuse queries under adversarial pressure is largely unmeasured in the public literature. We introduce BioRT-Bench, a benchmark that runs four attack methods (direct request, PAIR, Crescendo, and base64 encoding) against four frontier models (Claude Sonnet 4.6, GPT-5.4, DeepSeek V4-flash, Kimi K2.5) across 40 prompts spanning five biosecurity-relevant categories. Responses are scored by a calibrated judge extending StrongREJECT with two bio-specific dimensions: specificity and actionability. We measure Attack Success Rate (ASR), where 0 means the model fully refused and 1 means it provided specific, actionable bio-misuse content. Our results reveal a sharp robustness divide: Chinese frontier models (DeepSeek, Kimi) have under 5% refusal rates even under direct request (ASR 0.88 and 0.79), while Western models (Claude, GPT) maintain substantially stronger safeguards (ASR 0.15 and 0.16). Crescendo is the most effective attack across all models, both in bypassing refusal and in eliciting actionable content. Claude Sonnet 4.6 is the most robust model tested, achieving 100% refusal against base64-encoded prompts.

Read More

This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.
Apart Research logo

Sign up to stay updated on the
latest news, research, and events

Google Scholar icon

Apart Research Inc · 1500 N Grant St, Ste R, Denver, CO 80203 · +1 (720) 408-1923

Apart Research logo

Sign up to stay updated on the
latest news, research, and events

Google Scholar icon

Apart Research Inc · 1500 N Grant St, Ste R, Denver, CO 80203 · +1 (720) 408-1923

Apart Research logo

Sign up to stay updated on the
latest news, research, and events

Google Scholar icon

Apart Research Inc · 1500 N Grant St, Ste R, Denver, CO 80203 · +1 (720) 408-1923

This work was done during one weekend by research workshop participants and does not represent the work of Apart Research.
Apart Research logo

Sign up to stay updated on the
latest news, research, and events

Google Scholar icon

Apart Research Inc · 1500 N Grant St, Ste R, Denver, CO 80203 · +1 (720) 408-1923